BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25198100)

  • 1. Routes to induced pluripotent stem cells.
    Ruetz T; Kaji K
    Curr Opin Genet Dev; 2014 Oct; 28():38-42. PubMed ID: 25198100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation.
    Masip M; Veiga A; Izpisúa Belmonte JC; Simón C
    Mol Hum Reprod; 2010 Nov; 16(11):856-68. PubMed ID: 20616150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
    Ho PJ; Yen ML; Lin JD; Chen LS; Hu HI; Yeh CK; Peng CY; Lin CY; Yet SF; Yen BL
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
    Eminli S; Utikal J; Arnold K; Jaenisch R; Hochedlinger K
    Stem Cells; 2008 Oct; 26(10):2467-74. PubMed ID: 18635867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells.
    Jeong CH; Cho YY; Kim MO; Kim SH; Cho EJ; Lee SY; Jeon YJ; Lee KY; Yao K; Keum YS; Bode AM; Dong Z
    Stem Cells; 2010 Dec; 28(12):2141-50. PubMed ID: 20945330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
    Meissner A; Wernig M; Jaenisch R
    Nat Biotechnol; 2007 Oct; 25(10):1177-81. PubMed ID: 17724450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
    Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
    Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurosteroid dehydroepiandrosterone could improve somatic cell reprogramming.
    Shoae-Hassani A; Sharif S; Verdi J
    Cell Biol Int; 2011 Oct; 35(10):1037-41. PubMed ID: 21355850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A.
    Picanço-Castro V; Russo-Carbolante E; Reis LC; Fraga AM; de Magalhães DA; Orellana MD; Panepucci RA; Pereira LV; Covas DT
    Stem Cells Dev; 2011 Jan; 20(1):169-80. PubMed ID: 20504151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Pluripotency in Astrocytes through a Neural Stem Cell-like State.
    Nakajima-Koyama M; Lee J; Ohta S; Yamamoto T; Nishida E
    J Biol Chem; 2015 Dec; 290(52):31173-88. PubMed ID: 26553868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved method for the derivation of high quality iPSCs in the absence of c-Myc.
    Habib O; Habib G; Choi HW; Hong KS; Do JT; Moon SH; Chung HM
    Exp Cell Res; 2013 Dec; 319(20):3190-200. PubMed ID: 24095950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic Reprogramming-Above and Beyond Pluripotency.
    Meir YJ; Li G
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An overview of pluripotent stem cell lines].
    Kieffer E; Kuntz S; Viville S
    Med Sci (Paris); 2010 Oct; 26(10):848-54. PubMed ID: 20929676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function and regulation of mesenchymal-to-epithelial transition in somatic cell reprogramming.
    Shu X; Pei D
    Curr Opin Genet Dev; 2014 Oct; 28():32-7. PubMed ID: 25173869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of the inactive X chromosome and post-transcriptional reprogramming of Xist in iPSCs.
    Kim JS; Choi HW; Araúzo-Bravo MJ; Schöler HR; Do JT
    J Cell Sci; 2015 Jan; 128(1):81-7. PubMed ID: 25380819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.